← FDA Drug Approvals (Drugs@FDA)

TEVIMBRA

BLA · Biologics License Application · Sponsor: BEIGENE · Approved 2024-12-26

Drug application

FDA Application #

BLA761417

Application type

Biologics License Application

Brand name

TEVIMBRA

Generic name

Tislelizumab-Jsgr

Active ingredients

TISLELIZUMAB-JSGR

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BEIGENE

First approval

2024-12-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown